Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of JPI-289 in patients with acute ischemic stroke is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• JPI-289

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN